Medicine
Aripiprazole 30 mg orally disintegrating tablet
Aripiprazole 30 mg orally disintegrating tablet is a generic prescription medicine for oral use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Storage as on the product label
Key facts
- Active ingredient (INN)
- Aripiprazole
- Brand
- Sold under the generic name
- Strength
- 30 mg
- Dosage form
- Orally disintegrating tablet
- Route
- Oral
- Packs
- 30 tablets, 60 tablets, 90 tablets and 2 more
- Manufacturer
- Square Pharmaceuticals
- Origin register
- US FDA, United States
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N05AX12 Aripiprazole
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 20 July 2022
- Identifiers
- RxCUI 643019, 643022, 643027 +1DailyMed set ID 0f9b1fd8-a648-45c9-8655-14de07439f34NDC 76483-103Application ANDA090165
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, orally disintegrating in 1 bottle | 76483-103-00 | Square Pharmaceuticals | 20 July 2022 |
| 60 tablet, orally disintegrating in 1 bottle | 76483-103-01 | Square Pharmaceuticals | 20 July 2022 |
| 90 tablet, orally disintegrating in 1 bottle | 76483-103-02 | Square Pharmaceuticals | 20 July 2022 |
| 120 tablet, orally disintegrating in 1 bottle | 76483-103-03 | Square Pharmaceuticals | 20 July 2022 |
| 30 tablet, orally disintegrating in 1 carton | 76483-103-04 | Square Pharmaceuticals | 22 February 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Aripiprazole
Clinical summary
Aripiprazole is an atypical antipsychotic. It is available as tablets, orally disintegrating tablets and oral solution for intramuscular use. MedsAcross supplies Aripiprazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AripiprazoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ABILIFY prescribing information (Otsuka America Pharmaceutical) · U.S. National Library of Medicine, DailyMed
- Abilify Maintena: European public assessment report (EPAR) · European Medicines Agency
- Abilify: European public assessment report (EPAR) · European Medicines Agency
Need Aripiprazole 30 mg orally disintegrating tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.